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The  ability  of  a  cell  or  organism  to  direct  its 
movement  along  a  chemical  gradient  has  fasci- 
nated biologists for over  100  yr. This process of 
chemotaxis requires transformation of directional 
information from the environment into a series of 
cellular responses  resulting  in  directional move- 
ment.  Many lower organisms including bacteria, 
protozoa,  and  slime  molds  exhibit  chemotaxis. 
This ability helps them find nutrients, avoid nox- 
ious stimuli and aggregate at critical times in their 
development. Reports on  higher organisms indi- 
cate that primordial germ cells (32, 36), neurons 
(123),  tumor  cells  (124),  and  fibroblasts (115) 
exhibit chemotaxis. However, the leukocytes are 
the only vertebrate cells in which this ability has 
been shown definitively. Studies have focused on 
the chemotaxis exhibited by the neutrophilic pol- 
ymorphonuclear  leukocytes  (PMNs),  whose 
chemotaxis presumably facilitates their accumula- 
tion at sites of injury or infection. 
Chemical  gradients  are  important  in  morpho- 
genesis (27, 31,40, 75,105,106,151,162,173). 
A  gradient  can  impart  at  least  two  types  of 
information to a  given cell, positional and vecto- 
rial.  Positional information  is  derived  from  the 
mean concentration of a  given substance present 
around the cell. Positional information from gra- 
dients of diffusible substances has been implicated 
in the  organization of insect epidermis (90),  re- 
generation in hydra (174), and limb morphogene- 
sis (135,  148,  149).  Vectorial information at the 
cellular level depends on a  cell's ability to detect 
the direction of the chemical gradient and develop 
a polarity along this direction (31, 76, 90).  Most 
ceils  have  a  polarity  which  corresponds  to  the 
overall  tissue  architecture.  Some  polarities  un- 
doubtedly arise  from  localized stimuli  to  which 
cells respond. For example, local stimuli probably 
contribute  to  the  differentiation  of  the  luminal 
and basal sides of epithelial cells. We know macro- 
phages can selectively ingest opsonized particles, 
leaving other  unopsonized  particles attached  to 
their membrane (60). Motile cells, including slime 
molds (29)  and  fibroblasts (3),  are described as 
extending exploratory filopodia which,  upon  at- 
tachment to a suitable stimuli, induce cytoplasmic 
flow and expand into pseudopods. Other polariza- 
tions,  for example, the  direction of hair growth 
or  cell  migration,  may  be  due  to  gradients 
of  fixed  or  diffusible  agents  (31,  90).  If  the 
steepness of the gradient required for cell detec- 
tion  in  these  cases  is  similar to  that  needed  by 
leukocytes (discussed below),  one  would expect 
the  size  of  the  gradient  fields  to  be  relatively 
small, probably in the millimeter range. 
Since we do  not know  the chemical nature  of 
the gradient in most developmental systems, it is 
difficult to study the mechanisms involved in the 
establishment  of  cell  polarities.  In  the  case  of 
leukocyte  chemotaxis,  we  know  some  of  the 
chemical signals. Many factors have been  shown 
to be chemotactic for polymorphonuclear leuko- 
cytes (118,163) including: (a) serum factors (85, 
158,169,172),  particularly a fragment of the fifth 
component  of complement (22,  132,  137,  157); 
(b)  bacterial metabolites (86,  152);  (c)  cell-de- 
rived materials from sensitized lymphocytes (159) 
and  from  PMNs  (18,  30,  111,  181);  and  (d) 
denatured proteins (168). 
Recently, in an attempt to identify a chemotac- 
tic factor derived from bacteria, Schiffmann et al. 
examined the  possibility that N-formylmethionyl 
peptides  might  be  the  chemotactic  agents  since 
bacteria  initiate  their  protein  synthesis  with  N- 
formylmethionine (127).  They discovered that  a 
number of N-formylmethionyl peptides are in fact 
chemotactically active, some at very low concen- 
trations  (10 -1~  M)  (127,  134).  It  is  not  clear 
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chemotactic factors derived from bacteria. How- 
ever, the potency of their activity and the fact that 
other small peptides obtained from  washings  of 
sensitized lungs are also chemotactic suggest that 
peptides are natural mediators (56, 57). 
Since these peptides are active at low concentra- 
tions  and  can  be  synthesized  in  the  laboratory, 
they make excellent tools for studying chemotaxis, 
the  control of cell locomotion and  the  develop- 
ment of cell polarity. Over the last few years, they 
have  already  facilitated  major  advances  in  the 
study of leukocyte chemotaxis. 
In this review, I will begin by describing leuko- 
cyte locomotion and assays of leukocyte chemo- 
taxis, and then consider PMN chemotaxis as con- 
sisting  of  three  parts:  a  sensory  mechanism 
whereby the cell detects the presence of a stimu- 
lant and the direction of the gradient, a transducer 
mechanism by which the directional information 
gets transformed into cellular messengers, and an 
effector mechanism that  mediates the mechanical 
and  motile changes  which  produce  cell polarity 
and locomotion. I make no attempt to be compre- 
hensive but hope to indicate some recent advances 
in our understanding of PMN  chemotaxis. I  will 
focus particularly on studies investigating the cel- 
lular  responses  to  defined  peptide  attractants. 
Studies  on  nonmuscle  contractile  proteins  have 
been reviewed frequently and recently (see refer- 
ences  71,  113,  and  141).  I  will briefly mention 
some  studies  specifically on  leukocyte  proteins. 
Other interesting topics including chemotactic fac- 
tors specific for leukocytes other than neutrophilic 
PMNs, and the role of chemotaxis in the inflam- 
matory response and in various malignant condi- 
tions, are beyond the scope of this review. 
DESCRIPTION  OF  LEUKOCYTE  LOCO- 
MOTION 
Chemotaxis depends upon active cell locomotion. 
Manipulations which affect locomotion also alter 
chemotaxis. However, the reverse is not necessar- 
ily true since one could alter the ability to orient 
without affecting the locomotion itself. Polymor- 
phonuclear  leukocyte  locomotion  has  been  ob- 
served directly in vivo and in vitro and has been 
analyzed by time-lapse cinematography (63,  92, 
94, 116,117,175,176). 
The locomotion requires glycolytic energy (25, 
180), a temperature between 25 ~ and 40~  (104) 
and a  pH between 6.5  and 7.6  (23).  The  motile 
activities of leukocytes, locomotion, and  phago- 
cytosis, are in general tess sensitive to variations 
in  the ionic composition (11,  51,  93,  133,  165) 
than to the osmotic strength of the medium (93). 
Locomotion  is  inhibited  by  increasing  osmotic 
strengths  about  10%.  The  extent  of  inhibition 
does depend upon the molecular species used to 
increase the tonicity (93). Polymorphonuclear leu- 
kocytes  tolerate  hypotonic  media  well;  the  os- 
motic strength can be  reduced to about 50%  of 
the normal levels without decreasing the levels of 
locomotion (25, 93). 
Cells circulating in  the  blood stream  or incu- 
bated  in  nonstimulatory  medium  are  rounded. 
Without  stimulation,  PMNs  usually  remain 
rounded  and  do  not  extend  lamellipodia (181). 
Most chemotactic factors, when present homoge- 
neously  in  the  medium,  stimulate  the  rate  of 
locomotion  in  a  dose-dependent  manner  until 
locomotion is inhibited at high concentrations (85, 
165,  177,  181).  In early studies, the  stimulation 
of locomotion (chemokinesis) by chemotactic fac- 
tors was not recognized because the control cells 
were  in  a  serum-containing  medium  and  were 
moving rapidly (35,  99,  116).  When  stimulated 
by any of a number of agents including chemotac- 
tic factors, proteins, e.g.,  albumin,  materials re- 
leased from cells, and certain substrata, cells begin 
to extend lamellipodia, spread on a substrate and 
move randomly. Agents which, when present in a 
gradient, induce the cells to orient their locomo- 
tion are chemotactic. 
The  general  form  and  coordination  of  PMN 
locomotion is similar whether the cells are moving 
randomly  or  exhibiting  chemotaxis.  A  moving 
PMN  has a  polarized morphology which is char- 
acterized by a pseudopod in the front, a midregion 
containing the  nucleus,  and a  knoblike tail. The 
pseudopod  or  lamellipodium is  a  thin  layer  of 
cytoplasm (about  0.2  tzm  thick) which  excludes 
granules  and  mitochondria.  It  frequently  forms 
along the substrate in the direction of movement 
but also can  be projected into the fluid medium 
(4).  In contrast to the leading edge of a  moving 
fibroblast,  the  front  of  a  moving  PMN  rarely 
shows  ruffling.  Although  stationary  PMNs  can 
spread and have lamellipodia around their entire 
circumference,  the  lamellipodium  in  a  moving 
PMN is normally limited to the front of the cell or 
to a side when a cell initiates a turn. Furthermore, 
in PMNs, lamellipodia rarely form from the tail. 
The fact that lamellipodia are extended from the 
front or sides of a  moving cell is consistent with 
the  observation  that  cells usually make  turns  of 
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movement; the  mean  angle of turn is about  50  ~ 
(43,  92,  109,  129).  The  molecular basis for this 
polarity  and  inhibition of  pseudopod  formation 
from the tail is unknown. 
The  midsection of a  moving cell contains most 
of  the  cytoplasmic  granules  and  mitochondria 
present in PMNs.  The  granules are  usually con- 
centrated  toward  the  front  of  the  body  but,  as 
mentioned above, do not extend into the lamelli- 
podia. The nucleus remains toward the rear of the 
cell  and  the  centriole  is  normally  between  the 
nuclear  lobes  and  in  front  of  the  bulk  of  the 
nucleus (17, 43, 96). The distribution and move- 
ment of  the  granules indicate both  the  physical 
state  of  the  cytoplasm,  a  gel  or  sol,  and  the 
direction of cytoplasmic flow. In the region ante- 
rior  to  the  nucleus,  the  granules  often  exhibit 
Brownian  motion;  thus,  the  cytoplasm  in  this 
region is in the form of a sol. In the lamellipodia, 
and  cortex  of  the  body,  granules are  either  ex- 
cluded  or,  if  present,  do  not  exhibit  Brownian 
motion  (33).  In  these  regions,  the  cytoplasm  is 
believed to be in a gel or solid form (33,  35, 43, 
92,129). The gel-like nature of the cortex is also 
evident from the stability of its form. Film tracings 
of cells demonstrate  that  certain features  of the 
cell  outline  are  conserved  as  the  cell  moves. 
Irregularities  in  the  surface  of  the  cell  such  as 
protrusions  and  concave  indentations  often  re- 
main stationary relative to the substrate while the 
cytoplasm inside flows forward  (see  Fig.  1).  The 
concave  indentations  have  been  interpreted  as 
signs of cell contraction (92).  Alternatively, they 
may indicate a skeletal rather than (or in addition 
to) a contractile function since the indentations do 
not normally increase in depth or move relative to 
the  substrate  until they  are  included in the  con- 
striction at the base of the tail. 
The  tail of a  PMN  usually appears  as the  cell 
translocates on a  substrate.  It contains granules, 
mitochondria and occasionally even a  lobe of the 
nucleus. Granules in the tail do not exhibit Brown- 
ian motion (92) but at times flow forward out of 
the tail. This often occurs as the tail decreases in 
size, as though  a  contraction of the tail expelled 
its cytoplasm (42). 
Direct  observations  indicate  that  PMNs  are 
primarily adherent in the front (4, 33, 92).  With 
an  interference  contrast  microscope,  regions  of 
close adherence to the substrate can be seen under 
the lamellipodia, cell body, tail and tips of retrac- 
tion  fibers.  None  of these  adhesion  sites  are  as 
close to the substrate as those seen in fibroblasts 
(4).  On  adhesive  substrates,  cells  flatten  and 
retraction fibers are prominent; the tail can be so 
elongated  that  it  has  almost  no  constriction  or 
knoblike appearance.  It is not essential for loco- 
motion that  the  tail adhere  to  the  substrate.  As 
cells turn, the tail can sometimes be seen to swing 
around to its new position, indicating that it is not 
stuck to the substrate  (33,  92).  Retraction fibers 
are thin strands of cytoplasm filled with microflla- 
ments which typically extend from the distal side 
of the tail. These fibers are pulled out as the cell 
moves past  its sites of adhesion.  Each retraction 
fiber ends on a  bit of substrate where  an attach- 
ment site had been previously formed by a lamel- 
lipodium or the cell body (117).  Eventually, the 
fibers are pulled up from the substrate or break, 
Fmu~  1  Neutrophiles K and F at 2.5 s intervals. The lines represent a constant distance from the edge 
of the field; the constriction rings through which the lines pass remain fixed in space while the cells move 
forward.  Figure by Warren Lewis (92). 
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resorbed into the tail. Retraction fibers can occa- 
sionally pull a poorly adherent cell backward. 
Concanavalin A, other lectins and general de- 
bris from  the  culture dish  are  transported back 
over the surface of the cell to the tail of a moving 
cell (125). The molecular mechanism of transport- 
ing particles back may be similar to that of trans- 
porting the cell forward against the adhesion sites 
to the substrate (1,  34).  Whether the cell or the 
particle moves would depend on the relative re- 
sistances to  movement of the  two  objects  (62). 
The  idea  that  transport  of adhesion sites  is  the 
basis of cell locomotion is attractive and may be 
partially true. However, locomotion would seem 
to involve more than a capping of adhesion sites 
since  it  is  inhibited by  cytochalasin  B  and  en- 
hanced  by  increased  levels  of  cGMP  while  the 
capping of surface-bound concanavalin A  occurs 
in the presence of cytochalasin B and is reduced 
by increased levels of cGMP (110,125). 
METHODS  OF  EVALUATING  CHEMO- 
TAXIS 
To demonstrate chemotaxis, it is not sufficient to 
show that a given agent can cause cell accumula- 
tion or asymmetric spreading of a population of 
cells  since both phenomena could arise from an 
action  of  the  agent  on  the  rate  (chemokinesis) 
rather than direction (chemotaxis) of locomotion 
(63, 64). If a substance inhibits or slows locomo- 
tion, cells that happen to move near that substance 
will  be  trapped  and  accumulate.  If  a  substance 
stimulates the rate of locomotion, cells  in higher 
concentrations of this substance will move longer 
distances over the  substrate.  The fact that  most 
leukocyte chemotactic factors do increase the rate 
of cell locomotion at moderate concentrations and 
inhibit  the  rate  at  high  concentrations  makes 
careful  consideration of  assay  systems  essential 
(163, 167,177,181). Two basic types of systems 
exist  to  detect  and  measure  chemotaxis.  In the 
first, one measures changes in the distribution of a 
population  of cells after  correcting for  chemoki- 
netic effects of the test agent (95,163,167,181); 
in  the  second,  one  analyzes  the  movement  of 
individual  cells (35,  43,  63,  92,  93,  109,  116, 
129,176). 
The most common assay for measuring changes 
in  the  distribution  of a population  of  cells  is  a 
Millipore filter system first described by Boyden 
and since used to identify a number of chemotactic 
agents (22).  In this sytem, cells  are placed on a 
Millipore filter (with 0.65 to 5 /zm pores), and a 
gradient of the  agent to  be tested is established 
across the filter. One can then analyze the redis- 
tribution of the population by measuring (a) the 
distance that the cells have moved into the filter 
or (b) the number of cells that have moved a set 
distance into or completely across the filter after a 
given period (46, 54, 84,181). If either measure 
shows  an  increase  when  a  test  agent  replaces 
buffer beneath the filter, the agent has often been 
considered to be chemotactic. However, this assay 
is not a definitive test of chemotaxis, it measures 
a stimulation of cell migration which could be due 
to either chemotaxis, chemokinesis, or both. The 
Millipore system can be adapted into a true test of 
chemotaxis if the  chemokinetic effects  of a  test 
substance are first determined and then corrected 
for when evaluating the chemotactic response (95, 
163,  167, 177,  181). Similarly, the evaluation of 
leukocyte  chemotaxis  in  a  new  under  agarose 
assay  (107,  108)  is  not definitive unless correc- 
tions  are  made  for  the  chemokinetic effects  of 
various concentrations of test agents. 
Observing  and  measuring  the  movements  of 
individual cells with microscope techniques yields 
detailed information on a variety of parameters of 
the movement including the variation among the 
cells of the population or in a given cell at different 
times (176). One can evaluate aspects such as the 
rate of locomotion, the frequency or magnitude of 
turns, and the orientation of movement relative to 
the  gradient.  Interpretation of  results  with  this 
method is straightforward and much of what we 
know  about  the  behavior  of  cells  that  exhibit 
chemotaxis has come from microscope studies. 
SENSORY ASPECTS OF CHEMOTAXIS 
Behavioral Studies 
A  great deal can be learned about the sensory 
abilities of leukocytes by analyzing their chemo- 
tactic  behavior  under  controlled  conditions. 
Studying  bacterial  chemotaxis,  MacNab  and 
Koshland (94) outlined two basic ways in which a 
cell can sense the direction of a chemical gradient. 
It can take a concentration reading at one point, 
move a certain distance, take a second concentra- 
tion reading, and then compare the two readings. 
If the  second  concentration is  greater  than  the 
first,  then the  cell could  know that  it has  been 
moving up a concentration gradient. This has been 
termed  the  temporal  mechanism  of  sensing  a 
gradient since  the  cell  compares  the  concentra- 
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can compare the  concentration difference across 
its own dimensions and determine which side is in 
contact with the higher concentration. It has been 
argued that a cell or bacterium is too small to use 
this spatial mechanism (94).  Studies on bacterial 
chemotaxis have shown that bacteria are able to 
exhibit chemotaxis when the gradient across their 
own dimensions is only 10 -~ (a 0.01% difference 
in concentration across their dimensions) and un- 
der  conditions where  the  random fluctuation in 
the instantaneous local concentration of a chemi- 
cal would seem to make it impossible for a bacte- 
rium to detect this difference (94). Indeed, several 
studies have  shown that  the  bacterium does not 
sense the gradient across its own dimensions but 
rather uses the  temporal mechanism, comparing 
the concentrations as it swims. Since a bacterium 
swims  on  the  order  of  100  cell  lengths  before 
making a change in direction, the actual concen- 
tration difference that it is required to detect may 
be closer to 10 -z (1%) (14, 15, 94). 
The question of whether a leukocyte also must 
move in a gradient in order to detect its direction 
has  been  investigated.  Stationary  leukocytes 
placed in a gradient of chemotactic factor are able 
to initiate locomotion in the direction of the higher 
concentration of attractant.  Since they can start 
off in the correct direction, they must sense the 
gradient across  their own dimensions (178)  and 
are, therefore, using a spatial mechanism. 
Another difference  between  bacterial  chemo- 
taxis  and leukocyte chemotaxis  is illustrated by 
the  behavioral  mechanism with  which  the  cells 
orient their movement in a  gradient. The bacte- 
rium orients in the  gradient by altering the  fre- 
quency of its turns as a function of whether it is 
swimming up or down the gradient. There is no 
preferred direction of turn, but, merely by turning 
more  frequently  when  swimming  down  rather 
than up a gradient of attractant, most cells at any 
given time move up the gradient (14). This form 
of orientation was  called phobotaxis in the early 
1900's  because  it  was  believed  that  the  cells 
appeared  to turn away from a  negative environ- 
ment (39). This seems to be characteristic of most 
organisms which  use  a  temporal  mechanism of 
sensing the gradient (39). In contrast, leukocytes 
orient their movement primarily by turning in the 
preferred direction, i.e., into the steepest part of 
the gradient and not by altering the frequency or 
magnitude of their turns (16, 116,176). They can 
turn directly toward a new attractant, such as an 
erythrocyte  lysed  with  a  laser  beam  (16)  or  a 
pipette  containing chemoattractant (116).  Thus, 
leukocytes  orient  their  locomotion  toward  the 
chemotactic  source,  i.e.,  exhibit topotaxis  (39). 
This process involves vectorial or directional re- 
sponses to the gradient rather than merely quan- 
titative ones. Topotaxis is also exhibited by certain 
lower organisms, including slime molds (98). The 
nematode  is  an  example  of  an  organism  that 
appears to use a form of temporal discrimination 
and yet exhibits topotaxis  (160).  In theory,  the 
temporal mechanism requires only one chemotac- 
tic receptor and a memory system (94) while the 
spatial mechanism of the leukocyte requires mul- 
tiple receptors across the cell's dimensions (or one 
mobile receptor which could be moved across the 
cell). 
The  accuracy of leukocyte orientation can  be 
measured by the  McCutcheon index: the ratio of 
the length of a straight line toward a chemotactic 
source to the length of the path the cell actually 
took. In some studies, the index has been as high 
as  0.85  (35,  64,  116,  176).  The  accuracy  of 
orientation also can be evaluated by determining 
the direction of movement of each of the cells in a 
population relative to a direct line to the chemo- 
tactic  source.  In  appropriate  gradients,  at  least 
60%  of the  cells  orient within 30  ~ of the  direct 
line to the attractant (176, 178,179). 
Many external factors that induce cell changes 
do  so by interacting with specific  cell receptors. 
Stimulation of  functions such  as  locomotion or 
enzyme release  may occur when any given per- 
centage of the receptors  are  bound. In contrast, 
for  chemotaxis  the  cell  must  be  able  to  detect 
differences in the  concentration of an agent, not 
merely  its  absolute  concentration (138).  If  the 
chemotactic factor effects a cell response by inter- 
acting with a cell receptor which has typical bind- 
ing characteristics, one would expect that the cell 
would best be  able  to  sense a  difference in the 
concentration of a  factor and exhibit chemotaxis 
at  the  concentration of the  dissociation constant 
(Kd)  of  the  receptor  when  about  50%  of  the 
receptors  are  bound.  At  this  concentration,  a 
given  change  in  the  amount  of  factor  present 
would result in a maximum change in the number 
of receptors occupied across the cell dimensions. 
At lower concentrations, most receptors would be 
unoccupied  and  at  higher  concentrations  most 
receptors would be saturated. Thus, by determin- 
ing the  concentration at  which  the  cells  exhibit 
optimal chemotaxis in  a  standard gradient, one 
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that factor to the ceil (179). 
Such  studies with  peptide  chemotactic factors 
have been done, and the predicted binding con- 
stant does correspond to the  one measured with 
radioactive peptides  (170,  178,  179,  181).  The 
optimal concentration range can also be used to 
examine the sensitivity to the cell to detect differ- 
ences in the concentration of an attractant across 
its dimensions. In the optimal range, PMNs orient 
with a 1% concentration difference of a chemotac- 
tic peptide across their dimensions (179). 
Structural Requirements of 
Peptide Factors 
The  discovery  by  Schiffmann that  small  syn- 
thetic peptides are chemotactic for neutrophils has 
made possible systematic studies of the structural 
features  of  the  peptides  that  account  for  their 
activity. More than 20 peptides have been tested 
to  determine  the  concentration of  each  which 
stimulates the migration of cells into a  Millipore 
filter (134). The results are expressed in terms of 
the  concentrations required  for  a  half-maximal 
response:  EDs0,  the  end  dose  or  concentration 
which stimulates 50% of the maximal cell migra- 
tion into the filter. The ability of a given peptide 
to induce a  response at  low concentrations, low 
EDs0,s,  depends on  a  number of structural fea- 
tures. The N-formyl group is important in confer- 
ring activity; omitting the formyl group or replac- 
ing it with the bulkier N-acetyl group increases the 
concentrations of  peptide  required  to  get  a  re- 
sponse (127). Thus, while F-Met-Leu-Phe has an 
EDs0 of 7  ￿  10 -11 M, Met-Leu-Phe has an EDso of 
7  ￿  10  -r  M  (134).  The  methionine, although 
effective as the amino terminal amino acid, is not 
essential.  As  long  as  the  second  amino acid  is 
neutral and  nonpolar, the  activities are  similar; 
thus F-Met-Leu, F-Met-Phe, and F-Met-Met all 
have an EDs0 of between 4 and 9  ￿  10  -r M. A 
peptide with an acidic, F-Met-Glu, or a basic, F- 
Met-His, second amino acid has a lower activity 
(increased  concentrations  are  required)  (134). 
Phenylalanine in the third position increases the 
activity of a peptide. This effect is not merely due 
to an additional amino acid since F-Met-Met-Met 
has an EDs0 of 5  x  10 -9 M, and F-Met-Met-Ala 
has an EDs0 of 5  x  10  -r M. The order and not 
merely the  hydrophobic character  of the  amino 
acids is important; inverting the final two amino 
acids of F-Met-Leu-Phe to F-Met-Phe-Leu lowers 
the  EDs0  by  threefold  to  5  x  10 -8  M.  The 
peptides appear to act at the cell surface since F- 
Met-Leu-Phe-Lys-Inulin  is active (6). 
In  addition  to  stimulating cell  migration,  at 
increased concentrations (2- to 10-fold), the pep- 
tides are able to induce lysosomal enzyme release 
from cells on a substrate such as a Millipore filter 
or from cells treated with  10  /zg/ml cytochalasin 
B. The concentration of each peptide needed to 
induce enzyme release is correlated with the con- 
centration required to  stimulate migration. This 
was shown by a coefficient of correlation, r =  0.98 
for 24 peptides which had  peak chemotactic ac- 
tivities at concentrations between 10 -4 and 10 -11 
M. The parallel doses required for chemotaxis and 
lysosomal enzyme release indicate that the same 
peptide-receptor  interaction leads  to  both  func- 
tional responses (134).  In the  presence of cyto- 
chalasin B, 88  +  19% of the total lysozyme and 
53  +  7%  of total  cell  B  glucuronidase can  be 
released  by  peptides.  Slightly  higher  concentra- 
tions of peptide  are  required  to  induce release 
of B  glucuronidase than lysozyme. The  enzyme 
release requires external calcium (13). The basis 
for  the  enhancement by  cytochalasin  B  is  not 
clear.  An interesting study has  recently demon- 
strated that cytochalasin B greatly enhances fluxes 
of calcium and  sodium into PMNs  treated  with 
F-Met-Leu-Phe (103). These increased fluxes may 
effect  the enzyme release (103).  Also unclear is 
the  physiological significance of enzyme release. 
The  released  digestive  enzymes  could  aid  cell 
movement through  the  tissues.  In  addition, the 
factors  released  may  play  a  role  in  modulating 
the inflammatory response. 
The ability of chemotactic factors to induce lyso- 
limited to these synthetic peptides but appears to 
be true of most chemotactic factors, including C5a 
and denatured proteins (12,  13,  58,  163). 
The  functional studies  to  date  would  suggest 
that  a  single receptor-ligand interaction leads to 
stimulated  locomotion  (chemokinesis),  chemo- 
taxis,  and  enzyme  release,  and  that  these  re- 
sponses occur in different, but overlapping, dose 
ranges  (134).  At  low  doses,  the  stimulation of 
locomotion  is  the  first  response  observed.  At 
moderate doses, presumably near the Kd, chem- 
otaxis and rates of locomotion are  optimal. The 
dose-response  curve  for  enzyme  release  in  the 
presence of cytochalasin B is sharp, perhaps indi- 
cating  that  a  relatively  high  percentage  of  the 
receptors must be occupied to stimulate release. 
Peptide Receptor 
The  binding of tritiated  peptides  to  PMNs  is 
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The  binding  constants  of  both  formylnorleucyl- 
leucyl-phenylalanine (F-Norleu-Leu-Phe) to  rab- 
bit peritoneal PMNs (5) and of F-Met-Leu-Phe to 
human  PMNs  (170)  are similar to those concen- 
trations of the peptide which gave optimal chem- 
otactic  responses  (5,  170).  The  number  of  F- 
Norleu-Leu-Phe  binding  sites  on  rabbit  cells  is 
estimated from  a  Scatchard plot to be  105  while 
the  human  cells are estimated to have only 2  ￿ 
103 sites/cell for F-Met-Leu-Phe. 
The  failure  of several other tissues, including 
rat erythrocytes, human  platelets, circulating hu- 
man  iymphocytes, and  rat  brain  synaptic  mem- 
brane, to show high affinity binding is indicative 
of tissue specificity (5,170). The functional speci- 
ficity  is  demonstrated  by  the  ability  of  other 
peptides  and  a  bacterially  derived  chemotactic 
factor to  compete  for  the  binding  at  concentra- 
tions  paralleling their  potencies  as  chemotactic 
agents (5,  134,  170).  The  correlation coefficient 
for  concentration  of  peptide  for  half-optimal 
chemotaxis and the concentration which inhibited 
one half of the binding was 0.998 in the studies on 
human cells. 
The ability of 12 different peptides to compete 
for  binding  at  concentrations  corresponding  to 
those of their optimal chemotactic activity suggests 
that  many of the structural features required for 
chemotaxis are related to the ability of the peptide 
to bind to the receptor (5,134,  170). 
In addition to the affinity of a  peptide for the 
binding site, one can examine the efficacy of the 
binding, that is, the ability of the bound molecule 
to  induce  activation.  Although the  data  are  not 
yet sufficiently precise for  detailed analysis, the 
binding of F-Norleu-Leu-Phe to rabbit cells shows 
some  variation in the  ratio of the  EDs0  (for the 
migration assay) and the IDs0 (dose which inhibits 
50% of the F-Norleu-Leu-Phe binding) for differ- 
ent  peptides.  These  ratios varied between  0.11 
and 2. Of the peptides examined, F-Met-Leu had 
the  highest EDs0:IDs0 ratio; F-Met-Leu-Glu had 
the  lowest.  The  two  peptides  with  a  carboxy 
terminal  phenylalanine  had  relatively  low 
ED50:IDs0  ratios  (0.2).  These  data  suggest  that 
the carboxy terminal phenylalanine is particularly 
important for the efficacy of the interaction while 
the N-formylmethione gives the peptide a higher 
affinity  for  the  binding  site.  In  studies  on  the 
ability of various inactive tripeptides to inhibit the 
chemotactic activity of the tetrapeptides, Val-Gly- 
Ser-Glu  or  Ala-Gly-Ser-Glu,  on  eosinophils, 
Goetzl and Austen concluded that the amino end 
of the peptide was critical for the binding of the 
peptides to  the  cells while  the  carboxy terminal 
was important for activity (57). They also made a 
distinction  between  the  magnitude  of  the  cell 
response  induced  by  a  certain  peptide  and  its 
EDs0. These two measures of peptide activity are 
not correlated. Thus,  Leu-Gly-Ser-Glu had peak 
activity at a lower dose than did Ala/Val-Gly-Ser- 
Glu, but the magnitude of the cell response was 
never as high as that caused by Ala/Val-Gly-Ser- 
Glu  (57).  Information  on  peptide  receptors  in 
eosinophil PMNs has been recently reviewed (19). 
In  MiUipore  filter  assays  of  chemotaxis,  the 
peptides require  the  presence  of albumin  to  be 
active. The peptides do bind to albumin and can 
be  eluted  from  a  Sephadex  column  with  the 
albumin peak (166). However, cells orient toward 
peptides in the absence of protein in a visual assay 
system (178,  181), and the binding occurs in the 
absence of albumin or other proteins in the me- 
dium (5,170). 
Although various active formyl methionyl pep- 
tides compete with one another for binding to the 
receptor, C5a does not compete for the peptide- 
binding site even when it is present at concentra- 
tions well above those which cause maximal chem- 
otaxis. Thus, there must be more than one type of 
chemotactic receptor. Oxidized lipids, reported to 
be chemotactic, also do not compete for binding 
(153,  170). The number of receptors required to 
account  for  the  diverse  variety  of  chemotactic 
agents  is  not  known.  It  will  be  of  interest  if 
denatured proteins compete for the peptide-bind- 
ing site since this might suggest that "nonspecific" 
chemotactic (and phagocytic) agents have specific 
sequences that signal their denatured form. Alter- 
natively, factors such  as  denatured  proteins and 
alkylated albumin may have different receptors or 
interact with the membrane via relatively nonspe- 
cific hydrophobic forces (163,  170). The topic of 
membrane receptors on PMNs has been recently 
reviewed by Henson (68). 
TRANSDUCER  MECHANISMS 
The  binding  of  chemotactic  factors  to  the  cell 
membrane initiates a series of molecular changes 
culminating  in  directed  locomotion.  These 
changes control the activation of the  mechanical 
features involved in chemotaxis. Studies of trans- 
ducer mechanisms are complicated in the case of 
leukocyte chemotaxis by the fact that the chemo- 
tactic factors do not act merely to orient the cells. 
Most chemotactic factors also stimulate the rate of 
cell  locomotion  (are  chemokinetic)  and,  under 
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enzymes from cells. These related responses make 
it  difficult  to  interpret  the  various  molecular 
changes  which  include alterations in ion levels, 
membrane potentials, cyclic nucleotides, and hy- 
drolytic enzymes which  occur  upon  addition of 
chemotactic factors (9, 20, 44, 45, 47, 48, 51, 55, 
66,  69,  70,  73,  74,  88,  101,  102,  155,  156). 
Certain messages must contain directional infor- 
mation,  while  others  may  be  activators  of  the 
motile processes. An understanding of the trans- 
duction process  should  contribute to  an  under- 
standing of cell motility. I will discuss  only some 
of the more recent studies on possible transducers. 
For further information, the  reader can refer to 
several recent reviews (48, 50,118, 163). 
Ionic Requirements for Chemotaxis 
Involvement of  changes  in  the  internal ionic 
environment in  the  regulation of  chemotaxis  is 
appealing since  this  could  be  controlled by  the 
chemotactic  receptor's  altering  the  membrane 
permeability. Examples  of permeability changes 
induced by a membrane receptor exist, including 
some which require threshold levels of stimulation 
followed  by  a  non-excitatory refractory  period 
(82). Such features could contribute to the leuko- 
cyte directional response. 
Leukocyte locomotion and chemotaxis are  re- 
markably persistent in media of varied ionic com- 
position. The absence of potassium in the external 
medium has little or no effect on cell locomotion 
(133,  165)  although  Showell  and Becket  (133) 
report a decreased sensitivity to chemotactic fac- 
tors  by cells  incubated in the  absence of potas- 
sium. The presence of ouabain, an inhibitor of the 
sodium-potassium-ATPase,  also  decreases  the 
sensitivity to  chemotactic  factors  but  has  little 
effect on maximal rates of locomotion (133,165). 
Cells can move in the absence of external sodium, 
and in fact, the levels of random locomotion are 
stimulated when all of the sodium is replaced by 
potassium, choline, or even glucose. Even in the 
absence of calcium, cells can move at about 50% 
of their normal levels (11, 51,93,165). However, 
in the  presence  of  10 -z  M  LaClz  which  blocks 
transmembrane calcium movements, locomotion 
is  inhibited (20).  In  a  visual assay  system,  cell 
polarization in a chemotactic gradient can develop 
in the absence of calcium and in the presence of 1 
mM  EDTA or  ethylene glycol-bis(/3-aminoethyl 
ether)N,N,N,N'-tetraacetate (EGTA) (178,  179). 
Although the decreased locomotion in the ab- 
sence of calcium could be due to effects  on cell- 
substrate adhesions or to nonspecific effects, such 
as  effects  on membrane stability, calcium levels 
probably are critical to some aspect of the motile 
apparatus (71). 
Ionic Fluxes Associated with Addition 
of Chemotactic Factors 
In spite of normal locomotion in various ionic 
media, chemotactic factors do induce changes in 
the  fluxes  of  Z~Na, 42K, and  45Ca across  PMN 
membranes  (20,  44,  48,  51,  101,  102,  103). 
Using these radioactive elements, one can look at 
a change in the uptake from the medium (influx), 
a change in the rate of loss from a cell previously 
equilibrated with the element (efflux), or a change 
in the amount of ceil-associated label (intracellu- 
lar)  under  equilibrium conditions. N-formylme- 
thionyl peptides  increase the  rate  of 22Na influx 
into rabbit peritoneal exudate PMNs up to four- 
fold. The initial rate  of influx, measured after 5 
min, is  proportional to  the  concentration of  F- 
Met-Leu-Phe between 1 ￿  10 -l~  and 3 ￿  10 -9 M. 
The optimal concentration of peptide for sodium 
influx is higher than that which maximally stimu- 
lates locomotion (101,  102). After a 5- to 7-rain 
lag, an increase in sodium efflux  and 42K  influx 
(20% increase) is observed. These later fluxes can 
be inhibited by  10  -5  M ouabain, suggesting that 
the  Na  +,  K+-ATPase has  been stimulated (10). 
The peak peptide concentration for this K + influx 
is  about  3  ￿  10 -1~ M  F-Met-Leu-Phe, close  to 
that of maximal migration. No  change in potas- 
sium efflux is observed. 
The efflux, influx, and internal pool of calcium 
are  increased  in  polymorphonuclear leukocytes 
treated with chemotactic factors. A marked efflux 
was  noted in human cells  treated with C5a  (20, 
51) or in rabbit cells treated with 10  -9 M F-Met- 
Leu-Phe (101,  102).  In experiments which used 
higher  concentrations of  chemotactic  agents  or 
included LaCI3 washes, a net influx of calcium is 
also seen (20,  101,  102). This influx requires at 
least  0.25  mM  calcium in the  external medium 
and can be blocked by 1 mM La  +3 (20,101,102). 
The  calcium  uptake  results  in  an  increase  in 
intraceUular calcium comparable in magnitude to 
the increase that stimulates contraction in skeletal 
actomyosin (20).  Increased pyroantimonate pre- 
cipitate  in  human neutrophils treated  with  acti- 
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calcium levels (48). 
Further information regarding the ionic changes 
occurring upon addition of the chemotactic factors 
comes from studies on changes in the membrane 
potentials. Using a fluorescent dye, Seligmann et 
al. (128) have obtained evidence for a change in 
membrane potential of PMNs that were exposed 
to F-Met-Leu-Phe. Thus far, there have been no 
microelectrode studies measuring potential changes 
in PMNs, but Gallin and Gallin (44) and Gallin et 
al. (48) have recorded them from cultured human 
macrophages  stimulated  by  various  chemotactic 
factors including kallikrein, C5a, and F-Met-Leu- 
Phe  (44,  48).  Although the responses are varia- 
ble, 80% of the cells examined show some change 
in  membrane  potential. About 20%  of the cells 
have a brief, 3-s depolarization which is followed 
by a  more sustained, 20-s or longer hyperpolari- 
zation  -10  to  -50  mV  in  amplitude. In nearly 
60%  of  the  cells,  the  hyperpolarization  is  not 
preceded by a  measurable depolarization. A  sec- 
ond potential change can be stimulated by remov- 
ing the source of chemotactic factor and reintro- 
ducing it; however, several repeated stimulations 
result  in  desensitization.  The  evoked  potential 
changes are inhibited by 2.5  mM  Mg  ++ with 5.0 
mM EGTA. 
This hyperpolarization is associated with a  de- 
crease  in  membrane  resistance  as monitored  by 
the decreased electrotonic potential produced by 
constant current pulses (44, 48). The  membrane 
potential at which the  depolarizing response  dis- 
appeared  (the  reversal  potential)  was  0  inV. 
These authors postulate that  a  reversal potential 
of 0 mV is compatible with depolarization result- 
ing from a concomitant increase in the permeabil- 
ity of Ca  ++ or Na  + (flowing in) and  K + (flowing 
out). The reversal potential for the hyperpolariz- 
ing response was -70 mV which could arise from 
increased potassium permeability (44, 48). Gallin 
and Gallin and  Gallin et al. suggest that  a  small 
transient  Ca  ++  or  Na  §  influx  is  followed  by  a 
larger,  prolonged  potassium  efflux  causing  the 
hyperpolarization (44,  48). The emphasis on the 
hyperpolarization's being due to  a  potassium ef- 
flux puts the recording data at odds with the flux 
studies  where  the  major  change  noted  was  the 
large sodium influx (101,102).  Such comparisons 
are  probably premature  since  the  cell type,  the 
time-courses of the events being examined and the 
doses  of  chemotactic  factors  used  are  not  the 
same. The possibility remains that some or all of 
these changes are more relevant to enzyme release 
induced  by  the  chemotactic factors  than  to  the 
chemotactic  response.  Recent  evidence  from 
Becker's lab supports this possibility (103). 
Digestive  Enzymes Associated with 
Leukocyte Chemotaxis 
A  number of studies have focused on defining 
the  role  of  various  proteolytic activities in  the 
leukocyte  chemotactic  response.  Cell  proteases 
may have a role in the production (157,  171) and 
destruction (6) of active peptides. Hydrolytic ac- 
tivities have  also  been  implicated in  permitting 
(53,  150,  156,  171)  and  inhibiting the  cell re- 
sponse  (53,  136).  In  addition,  as  mentioned 
above, under appropriate conditions chemotactic 
factors  stimulate  release  of lysosomal enzymes. 
The abundance of hydrolytic enzymes that may be 
secreted or leak from damaged cells and the use, 
in  some  studies,  of enzyme  inhibitors that  have 
toxic or nearly toxic effects on  the cells confuse 
the interpretation of the results. 
Several independent lines of evidence have im- 
plicated a  hydrolytic enzymatic activity in leuko- 
cyte locomotion (8, 9,154,156,163).  Studies by 
Becket and co-workers demonstrate that the inter- 
action of certain chemotactic factors with rabbit 
blood  PMNs  results  in  10-20%  increase  of  a 
leukocyte  chymotrypsin-like  esterase  activity 
which  can  cleave  acetyl-DL-phenylalanine B  na- 
phylester. The parallel inhibition of this enzymatic 
activity and  PMN  chemotaxis  by  various  phos- 
phonate  esters  and  aromatic amino  acid deriva- 
tives  suggested  to  Ward  and  Becker  that  this 
activity is essential for the chemotactic response 
(154,156; 1 see reviews, references 8 and 163). 
Recently, it has been demonstrated that rabbit 
leukocytes  can  digest  the  peptide  chemotactic 
factors (6). The digestive enzyme appears chymo- 
trypsin-like and can be inhibited with 0,1 mM L-1- 
(tosylamido  2-phenyl)ethyl chloromethyl  ketone 
(TPCK)  or  0.1  mM  benzoyltyrosine ethyl  ester 
(BTEE).  Since these inhibitors also prevent pep- 
tide stimulation of leukocyte locomotion and ly- 
sosomal enzyme release, Aswanikumar et al. have 
It is of interest that two chemotactic factors, kallikrein 
and  plasminogen  activator,  have  enzymatic  activities 
which seem essential for their chemotactic activity (49, 
80,81). 
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to the functional interaction of the peptide with 
the cell (6). Inhibitors with broad specificity such 
as macroglobulin (10/zg/ml) and human antitryp- 
sin (1  /zg/ml) are also reported to inhibit human 
PMN  chemotaxis  to  C5a;  most  trypsin  specific 
inhibitors do  not  block the  response  (53,  171). 
One can imagine the digestion (or energy derived 
from  the  digestion) of the  chemotactic agent  as 
being  critical for  a  transduction  process  in  the 
membrane;  however,  there  is no  conclusive evi- 
dence  that  such  a  protease is essential for loco- 
motion. The effective inhibitors are often irrevers- 
ible and have nonspecific actions which can dam- 
age the  cell (40).  The  digestive enzymes  associ- 
ated with leukocyte chemotaxis may be important 
in  destroying  chemotactic  factors  and  digesting 
and loosening intercellular spaces to permit PMN 
infiltration  rather  than  in  activating  the  motile 
response (77, 78). 
Incubation of cells with high concentrations of 
certain chemotactic factors (C5a, activated serum, 
and casein) (155)  but not others (bacterially de- 
rived factors) (9, 86,  155) leads to an irreversible 
inhibition of the  cell's ability to  respond to  any 
chemotactic  factor.  This  chemotactic  factor-in- 
duced inhibition has been termed deactivation. It 
is  most pronounced  when  cells are incubated in 
concentrations of chemotactic factors above those 
which  optimally stimulate  cell locomotion.  The 
inhibition  does  not  appear  to  be  factor-specific 
since  deactivation  with  C5a  inhibits  the  subse- 
quent cell response to bacterial factors as well as 
to C5a. Addition of certain phosphonate esters or 
aromatic amino acid derivatives to the incubation 
mixture prevents deactivation. Thus, deactivation 
may involve an esterase which is inhibited by the 
phosphonate esters (155). 
The requirement for high doses of chemotactic 
factors and the presence of calcium for deactiva- 
tion  and  the  protection  against  deactivation  by 
protease inhibitors suggest that the phenomenon 
may  be  mediated  at  least  in  part  by  released 
iysosomal enzymes  (122).  Gallin has  correlated 
an  inhibition of locomotion with  the  incubation 
conditions which induce iysosomal enzyme release 
(personal communication). Although the cells are 
perhaps damaged by the  enzymes, the  ability of 
deactivated cells to show increased hexose mono- 
phosphate shunt activity when treated with chem- 
otactic  peptides  suggests  that  the  cells  are  still 
viable and retain some receptor for the chemotac- 
tic interaction (55). 
Role of Cyclic Nucleotides 
Small  increases  (usually less  than  twofold)  in 
the  levels  of  cGMP  have  been  noted  in  both 
PMNs and monocytes after the addition of chem- 
otactic factors (66, 69, 70). Although cGMP itself 
does not appear to be chemotactic, drugs which 
increase  the  intercellular  GMP  levels,  such  as 
acetyl choline, carbonyl choline and imidole, en- 
hance  the  chemotactic  responses  (38,  66,  126, 
182).  On the other hand, the leukocyte response 
can  be  depressed  somewhat  by  incubating  with 
10-5-10 -4  M  dibutryl  cAMP  or  agents  which 
increase cAMP levels, such as prostaglandin E1 or 
epinephrine or theophylline (38, 121,122).  Tem- 
poral and quantitative discrepancies between the 
increases in intercellular cyclic nucleotides and the 
changes in chemotaxis and motility make interpre- 
tation of this data difficult (121,122).  In addition, 
there are conflicting reports regarding the chemo- 
tactic activity of cAMP. When assayed in a  Milli- 
pore system, its activity is weak if present at all 
(79,  91,  121,  145,  161,  163).  However, several 
workers report directed locomotion toward cyclic 
AMP when  assayed by direct microscope obser- 
vation (51,  61,  116).  The  basis for this discrep- 
ancy is unknown. 
A  number of molecules are probably involved 
in  the  transduction  process.  A  change  in  one 
parameter may lead to a series of changes which 
eventually control features of the motile appara- 
tus.  The  chemotactic  response  requires  that  at 
least one of these molecules have an asymmetric 
distribution along  the  direction  of the  gradient. 
The  degree of asymmetry might  not  directly re- 
flect the  steepness of the  gradient since the  cell 
response to the gradient is not a linear response to 
the absolute concentration of stimulant in contact 
with  the  cell surface.  With a  10%  difference in 
concentration across its dimensions, a  given  cell 
does not merely form  10%  more pseudopods on 
the high side, nor is there a mere 10% increase in 
the  number  of  cells  moving  up  the  gradient. 
Rather, there is a 900% increase in the number of 
cells  moving  up  the  gradient  (178,  179).  The 
molecular basis for this amplification and coordi- 
nation probably involves a competition across the 
cell dimensions. A  region of the cell surface with 
a  certain  percentage  of  receptors  bound  could 
undergo a  local change in  membrane permeabil- 
ity. This  change  could then  inhibit permeability 
changes in the rest of the cell for a certain time, 
and  thus  allow  a  directional response.  Alterna- 
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bound could cause the asymmetric distribution of a 
substance  required  for  a  particular function  such 
as  pseudopod  formation.  Further  knowledge  of 
the transducers which carry vectorial information 
will increase  our  understanding  of the  develop- 
ment of cell polarity. 
EFFECTOR  MECHANISM 
Work on the effector mechanisms has focused on 
defining the structures and proteins present in the 
leukocyte and  the  factors controlling their form 
and function in vitro. 
Microtubules 
Microtubules are  involved in the  maintenance 
of a polarized form in a number of systems (114). 
Thus, it is not surprising that the role of microtu- 
bules in leukocyte locomotion and chemotaxis has 
been of interest to a number of investigators. Most 
studies have used a pharmacological approach and 
examined cell responses in the presence of various 
antimitotic drugs, particularly colchicine and vin- 
blastine. These drugs do cause microtubule depo- 
lymerization in  PMNs  (7,  51,  58,  96,  97,  178, 
179).  Leukocytes are capable of active and even 
stimulated locomotion in the absence of polymer- 
ized  microtubules  (7,  13,  26,  37,  72,  96,  97, 
119).  Several studies show  that  the  chemotactic 
response can be decreased by colchicine and vin- 
blastine  (24,  96,  97,  162,  163).  Other  studies 
report little or no inhibition of PMN chemotaxis 
by colchicine (24,  178,  179).  Wilkinson showed 
that colchicine inhibited the directional response 
of  lymphoblasts  migrating  through  a  Millipore 
filter even  while  stimulating their  random  loco- 
motion (164). 
Since  most  cells  have  one  nucleus  and  one 
centriole,  an  acentric  location of either,  or  the 
alignment of these two organelles, gives the cell a 
polarity. In a  typical moving PMN,  the lobes of 
the nucleus are located toward the rear of the cell 
and  the  centriole  is  normally  in  front  of  the 
nucleus (18, 86). The cause and consequences of 
this  asymmetry  are  unknown,  but  microtubules 
are involved in its maintenance.  In the presence 
of colchicine, the position of the  nucleus in cells 
exposed to a chemotactic gradient is irregular (96, 
97).  The  relevance  of  this  disorganization  to 
chemotaxis is uncertain since cell orientation in a 
chemotactic gradient, as determined by a  vector 
drawn from the tail to the center of the lamellipo- 
dium, is only slightly decreased even in high (100 
p.g/ml) levels of colchicine (178,  179).  In  addi- 
tion, Keller and Bessis report oriented locomotion 
by cell fragments which lack both a centriole and 
a nucleus (83). 
Drug studies are of course limited by the possi- 
bility that  the  effects  are  not  specifically on  the 
microtubules. Both colchicine and vinblastine are 
known  to affect membrane  transport (100),  and 
these  drugs  have  been  shown  to  affect  PMN 
adhesion (89) and lysosomal enzyme release (12, 
13, 58, 67, 72,  111,  161). However, the involve- 
ment of microtubules in some aspect of the chem- 
otactic  response  is  further  suggested  by  studies 
showing an increased number of polymerized tu- 
bules in cells treated with chemotactic factors (51, 
58).  Cells  exposed  to  phagocytic  stimuli  and 
agents  which  increase  the  intercellular levels of 
GMP are also reported to have increased numbers 
of  tubules  (72,  161).  The  modulation  of  the 
chemotactic response by cyclic nucleotides may be 
mediated by alterations in the number of polym- 
erized tubules. 
Motile Apparatus 
In the leukocyte, as in other cells, workers are 
beginning to examine the molecular basis of mo- 
tile  functions  (28,  112,  113).  Already  there  is 
documentation for the presence of actin, myosin, 
a  cofactor  that  allows  actin  activation  of  the 
myosin ATPase, as well as an actin-binding protein 
that  combines with  actin  to form  a  gel which is 
sensitive to temperature and cytochalasin B  (65, 
130,  131,  141-144,  146).  Other  proteins  must 
contribute  to  the  motile  process. These  may in- 
clude other proteins prominent in muscle such as 
tropomyosin, troponin, and ct-actinin. This field is 
rapidly growing  and  has been  recently reviewed 
(71,113,141). 
To  understand  the  molecular basis of the  leu- 
kocyte  chemotactic  response,  we  will  want  to 
know the distribution in the moving cell of each of 
these  proteins  and  the  factors  controlling  their 
activity  and  structural  states.  The  organization 
must  result  in  the  coordinated  locomotion  de- 
scribed  above  including:  (a)  the  extension  of 
pseudopodia; (b) the presence of a cortical gel in 
the pseudopods and cortex and the constriction at 
the base of the tail; (c) the flow of cytoplasm into 
advancing pseudopods and out of the tail; (d) the 
formation, backward movement and breaking of 
attachments to the substrate, and (e) the  polari- 
zation of the cell in the chemical gradient. 
Although PMNs are the most rapidly moving of 
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their total protein as  actin, the fibrous elements 
seen by electron microscopy of moving PMNs are 
not impressive in their organization or quantity. 
They contain no prominent stress fibers of actin 
filaments such as those seen in fibroblasts. Rather, 
a filamentous network is visible particularly in the 
pseudopods, tail, and cortex. Perhaps the  amor- 
phous structure permits the rapid flexible move- 
ments characteristic of PMNs. With immunologic 
techniques, myosin can be seen to be distributed 
throughout  the  cytoplasm  (41,  131).  There  is 
some indication that lamellipodia are enriched in 
actin-binding protein (21,  141).  Actin filaments, 
100-A, filaments and microtubules align parallel to 
the cell surface in regions where the cell contacts 
a substrate. This organization is particularly prom- 
inent in macrophages (120). The activation of the 
motile apparatus must be mediated by the trans- 
duction process. Although there are indications of 
ionic  and  nucleotide  changes,  the  parameter(s) 
which regulates the motile apparatus remains un- 
known. Calcium is reported to alter the superpre- 
cipitation of a leukocyte extract containing acto- 
myosin (130), but it does not alter the activity of 
the  actin and cofactor  activated myosin ATPase 
from leukocytes (142, 143). The calcium may be 
affecting an actin-binding  protein gel since EGTA 
is required for the extraction of this protein from 
the cells (142). 
In other systems, protein modifications includ- 
ing phosphorylations and methylations have been 
shown to alter the myosin ATPase (2) or alter the 
properties of membrane receptors (59,147,153). 
Thus far, no analysis of leukocytes at this level has 
been made. The control of coordinated movement 
of a leukocyte is undoubtedly a complicated proc- 
ess. Genetic complementation  experiments in bac- 
teria indicate that at least nine gene products are 
required for the relatively simple chemotactic re- 
sponse  exhibited  by  these  organisms  (87).  The 
leukocyte response, both more flexible and more 
complicated than that of the bacterial form, must 
involve control over a  large  number of parame- 
ters. Progress will undoubtedly involved simplifying 
the system by examining the behavior of purified 
components in vitro and analyzing particular fea- 
tures of the  whole  cell behavior. The  ability to 
manipulate the cell orientation and rates of loco- 
motion with defined agents makes the leukocyte 
system useful for investigating the molecular basis 
of cell orientation and locomotion. 
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